[Mastocytosis. Clinical, immunological and therapeutic study].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002675:Child, Preschool; D002936:Cinnarizine / Q000627:therapeutic use*; D003169:Complement Inactivator Proteins / Q000627:therapeutic use; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D010879:Piperazines / Q000627:therapeutic use*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014582:Urticaria Pigmentosa / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D000893:Anti-Inflammatory Agents; D003169:Complement Inactivator Proteins; D007136:Immunoglobulins; D010879:Piperazines; D002936:Cinnarizine; D003165:Complement System Proteins; D011241:Prednisone
Mastocitosi. Contributo clinico, immunologico e terapeutico.